borderline significanceP = 0.0561
In addition, rs1131636 was also associated with local‐recurrence‐free survival of patients with NPC, with a borderline significance (HR = 1.20, 95% CI = 1.00–1.44, P = 0.0561, I 2 = 0%, P heterogeneity = 0.878; Figure S2 and Table S2, Supporting Information).